CHI Advisors LLC
NEW YORK, NY · CIK 1791468 · 13F filing filed 2022-08-12
No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.
- Legal entityCHI ADVISORS LLC (US)
- Others nearbyNew York, NY
$261.5m
reported value
+11.3% vs Q1 2022
25positions
82.9%in top 10
4 new
13 added
1 reduced
0 sold out
vs Q1 2022
Options: 2 call positions ($9.0k notional), 1 put positions ($372.0k notional) – listed below, not included above.
Holdings, Q2 2022
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| PROMETHEUS BIOSCIENCES INC COM | $47.2m18.05% | Added +86.9k |
| CULLINAN THERAPEUTICS INC CGEM | $39.1m14.94% | Added +294.6k |
| REPARE THERAPEUTICS INC RPTX | $37.0m14.16% | Added +65.7k |
| PLIANT THERAPEUTICS INC PLRX | $24.9m9.52% | Added +449.4k |
| VECTIVBIO HLDG AG ORD SHS | $20.4m7.81% | Added +697.9k |
| KEZAR LIFE SCIENCES INC COM | $15.2m5.82% | Added +1.5m |
| 2SEVENTY BIO INC TSVT | $10.8m4.14% | Unchanged |
| INOZYME PHARMA INC COM | $9.7m3.71% | Added +1.1m |
| COMPASS THERAPEUTICS INC CMPX | $7.5m2.87% | Unchanged |
| IKENA ONCOLOGY INC COM | $4.8m1.85% | Added +276.2k |
| PRECISION BIOSCIENCES INC COM | $4.8m1.84% | Added +2.4m |
| NKARTA INC NKTX | $4.4m1.69% | New |
| FREELINE THERAPEUTICS HLDGS SPONSORED ADS | $4.2m1.62% | Unchanged |
| OMEGA THERAPEUTICS INC COMMON STOCK | $4.0m1.53% | Unchanged |
| AKOUOS INC COM | $3.9m1.50% | Unchanged |
| G1 THERAPEUTICS INC GTHX | $3.8m1.45% | Added +278.6k |
| ORCHARD THERAPEUTICS PLC ORTX | $3.1m1.19% | Unchanged |
| ONCORUS INC COM | $3.0m1.14% | Reduced -50.0k |
| LARIMAR THERAPEUTICS INC LRMR | $3.0m1.14% | Unchanged |
| KEROS THERAPEUTICS INC KROS | $2.9m1.09% | Added +41.2k |
| CORVUS PHARMACEUTICALS INC CRVS | $2.2m0.84% | Added +511.0k |
| ENTRADA THERAPEUTICS INC TRDA | $2.0m0.76% | New |
| OVID THERAPEUTICS INC OVID | $1.9m0.71% | Added +11.9k |
| EIGER BIOPHARMACEUTICALS INC CLDN | $1.2m0.46% | New |
| PHASEBIO PHARMACEUTICALS INC PHAS | $450.0k0.17% | New |
Options (notional value)
| Underlying | Notional | Change |
|---|---|---|
| SPDR SER TR XBI · Put | $372.0k157.0k shares | Reduced |
| KEZAR LIFE SCIENCES INC Call | $5.0k100.0k shares | New |
| EIGER BIOPHARMACEUTICALS INC CLDN · Call | $4.0k25.1k shares | New |